PATENT CLAIM ANALYSIS

Application Number: 16032380
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-02
Patent Classification: ["514", "571000"]

Abstract:
Treatment of intrahepatic cholestatic diseases by therapy with seladelpar or a salt thereof.

Claim (Index 3):
The method of  claim 1  where the compound is administered orally.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 95.0
- Lexical Diversity: 1.0
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15496875', '15720849', '15271460', '14663027', '11914211']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8016019416088573
- 35 USC 102 Novelty (BERT): 0.5837564462960632
- Combined Prediction Score: 0.7798173920775779
- Mean Citation Score: 384.58848
- Max Citation Score: 468.86057
- Similarity Product: 456.322756448288

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test